Screening Trial News Today

Expression levels of several microRNAs in plasma samples can help predict the onset of pancreatic cancer up to 5 years prior to clinical diagnosis.

ROCKVILLE, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc. (Nasdaq: GLYC), a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today announced the 65th American Society of Hematology (ASH) Annual Meeting will feature two presentations o...

GlycoMimetics, Inc. , a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today announced the 65th American...

SAN DIEGO, Dec. 08, 2023 -- Kura Oncology, Inc. , a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, and The Leukemia...

SAN DIEGO, Dec. 08, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, and The Leukemia & Lymphoma Society (LLS), the largest private funder of blood cancer research, today announced a clinical collaboration to evaluate Kura’s menin inhibitor, ziftomenib, in combination with chemotherapy in pediatric patients with relapsed/refractory KMT2A-rearra...

Study, involving 117,673 participants from the PLCO Cancer Screening Trial, assessed the impact of vegetarian and vegan diets on all-cause mortality in the U.S. over an average follow-up of 18 years.

The standard risk calculator requires nine variables, and not all of them are always available in the EHR. The proposed CXR model has performed similarly to the standard model.

Research continues we will get to a point at some point in the future where we are able to prevent type one entirely. flan where we are able to prevent type one entirely-— one entirely. can i ask you one ruick one entirely. can i ask you one quick thing. — one entirely. can i ask you one quick thing, have _ one entirely. can i ask you one quick thing, have you i one entirely. can i ask you one quick thing, have you written i quick thing, have you written anything on the uk website about this...

To have them licensed so the screening trial is about preparing us for a time when we can delay type i us for a time when we can delay type 1 diabetes or even prevent it happening. it 1 diabetes or even prevent it happening-— 1 diabetes or even prevent it happening. 1 diabetes or even prevent it haueninu. , ~ ,., happening. it sounds like it is an interesting _ happening. it sounds like it is an interesting and _ happening. it sounds like it is an interesting and busy _ happening. it sounds li...

Pivotal data on glofitamab, a potential first-in-class CD20xCD3 T-cell engaging bispecific antibody, in heavily pre-treated patients with aggressive lymphoma, will be presented as part of our industry-leading